Show simple item record

dc.contributor.authorDesar, IME
dc.contributor.authorOttevanger, PB
dc.contributor.authorBenson, C
dc.contributor.authorvan der Graaf, WTA
dc.date.accessioned2017-12-19T14:25:30Z
dc.date.issued2018-02
dc.identifier.citationCritical reviews in oncology/hematology, 2018, 122 pp. 10 - 20
dc.identifier.issn1040-8428
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/977
dc.identifier.eissn1879-0461
dc.identifier.doi10.1016/j.critrevonc.2017.12.009
dc.description.abstractUterine sarcomas (US) are rare mesenchymal tumours of the uterus and are divided mainly into uterine leiomyosarcoma (uLMS), low grade endometrial stromal sarcoma (LG-ESS), high grade endometrial stromal sarcoma (HG-ESS), adenosarcomas and high grade undifferentiated sarcoma (HGUS). US are often high-grade tumours with a high local recurrence rate and metastatic risk. We here discuss the current standard of care and knowledge of systemic therapy for adult uterine sarcomas, in particular uLMS, LG-ESS, HG-ESS and HGUS, in both the adjuvant as well as the metastatic setting.
dc.formatPrint-Electronic
dc.format.extent10 - 20
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
dc.subjectHumans
dc.subjectSarcoma, Endometrial Stromal
dc.subjectLeiomyosarcoma
dc.subjectSarcoma
dc.subjectUterine Neoplasms
dc.subjectEndometrial Neoplasms
dc.subjectChemotherapy, Adjuvant
dc.subjectRadiotherapy, Adjuvant
dc.subjectAdult
dc.subjectFemale
dc.titleSystemic treatment in adult uterine sarcomas.
dc.typeJournal Article
dcterms.dateAccepted2017-12-12
rioxxterms.versionofrecord10.1016/j.critrevonc.2017.12.009
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
rioxxterms.licenseref.startdate2018-02
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfCritical reviews in oncology/hematology
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.publication-statusPublished
pubs.volume122
pubs.embargo.termsNo embargo
icr.researchteamClinical and Translational Sarcomaen_US
dc.contributor.icrauthorvan der Graaf, Wilhelmina


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record